Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Kezar Life Sciences Inc.

Kezar Life Sciences ( ($KZR) ) has issued an announcement. On April 1, 2026, Kezar Life Sciences terminated its lease for 48,714 square feet of off...

Kezar Life Sciences Announces Major Executive Leadership Changes

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aura Biosciences Inc (AURA) and Kezar Life Science...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aura Biosciences Inc (AURA) and Kezar Life Sciences (KZR)

The latest announcement is out from Kezar Life Sciences ( ($KZR) ). On March 30, 2026, Kezar Life Sciences agreed to be acquired by Aurinia Pharmac...

Kezar Life Sciences to Be Acquired by Aurinia

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biogen (BIIB) and Kezar Life Sciences (KZR). Bioge...

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Kezar Life Sciences (KZR)

Kalamazoo Resources Ltd. ( ($AU:KZR) ) has shared an announcement. Kalamazoo Resources has launched a major ~14,000-metre infill drilling campaign ...

Kalamazoo starts 14,000m infill drilling to advance Mt Olympus PFS

An update from Kalamazoo Resources Ltd. ( ($AU:KZR) ) is now available. Kalamazoo Resources has reported strong initial assay results from its Phas...

Kalamazoo’s Ashburton drilling extends Mt Olympus gold mineralisation

Kezar Life Sciences ( ($KZR) ) has provided an announcement. On March 6, 2026, Kezar Life Sciences agreed to sell its Sec61-based discovery and dev...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KZR	$7.38	-0.14%	97.97K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KZR	$7.38	-0.1%	97.97K
3
4
5
6

KZR

KZR

No Data Available

Get Kezar Life Sciences Inc. Data in Excel

Get Kezar Life Sciences Inc. Data in Excel